The store will not work correctly when cookies are disabled.
Ethyl (8-cyclohexyl-5-oxoimidazo[1,2-c]pyrimidin-6(5H)-yl)acetate
ID: ALA4764317
PubChem CID: 162661021
Max Phase: Preclinical
Molecular Formula: C16H21N3O3
Molecular Weight: 303.36
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)Cn1cc(C2CCCCC2)c2nccn2c1=O
Standard InChI: InChI=1S/C16H21N3O3/c1-2-22-14(20)11-18-10-13(12-6-4-3-5-7-12)15-17-8-9-19(15)16(18)21/h8-10,12H,2-7,11H2,1H3
Standard InChI Key: POGDPLBGCPIOGY-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
14.6352 -22.9804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6352 -23.7976 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.3404 -24.2021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0457 -23.7976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3404 -22.5677 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.0466 -22.9810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6579 -22.4371 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.3295 -21.6876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5153 -21.7684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9261 -22.5776 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.7526 -24.2076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7481 -25.0244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4541 -25.4344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1636 -25.0271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1626 -24.2057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4560 -23.7995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9280 -24.2072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9292 -25.0244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2221 -25.4340 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.6375 -25.4320 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.6387 -26.2492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3470 -26.6567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 5 1 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 5 1 0
1 10 2 0
4 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 11 1 0
2 17 1 0
17 18 1 0
18 19 2 0
18 20 1 0
20 21 1 0
21 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 303.36 | Molecular Weight (Monoisotopic): 303.1583 | AlogP: 2.11 | #Rotatable Bonds: 4 |
Polar Surface Area: 65.60 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.19 | CX LogD: 2.19 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.81 | Np Likeness Score: -1.04 |
References
1. Jansa J,Jorda R,Škerlová J,Pachl P,Peřina M,Řezníčková E,Heger T,Gucký T,Řezáčová P,Lyčka A,Kryštof V. (2021) Imidazo[1,2-c]pyrimidin-5(6H)-one inhibitors of CDK2: Synthesis, kinase inhibition and co-crystal structure., 216 [PMID:33711765] [10.1016/j.ejmech.2021.113309] |